Xaira

Xaira Therapeutics is an integrated biotechnology company applying artificial intelligence to reinvent the drug discovery and development process end-to-end. The company combines machine learning research, large-scale data generation, and therapeutic development to target previously undruggable diseases. Founded in 2023 and headquartered in South San Francisco, Xaira launched with over billion in funding and recently unveiled X-Cell, its first virtual cell model trained on the largest causal genome-wide perturbation dataset ever reported.